CryoVascular receives FDA clearance for vascular therapy device

CryoVascular of Los Gatos, CA, has received U.S. Food and Drug Administration clearance to market its PolarCath peripheral transluminal angioplasty system. The device is used for treating clogged leg arteries via a liquid nitrous oxide-filled balloon that opens the vessel. The device debuted at the Transcatheter Cardiovascular Therapeutics symposium in Washington, DC, this week. It is expected to be commercially available in the first quarter of 2003.

By AuntMinnie.com staff writers
September 27, 2002

Copyright © 2002 AuntMinnie.com

Page 1 of 181
Next Page